Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Clinical experience: a potential hazard.

Kopman AF.

Anesth Analg. 2012 Apr;114(4):915; author reply 915. doi: 10.1213/ANE.0b013e31824abd4b. No abstract available.

PMID:
22434898
2.

Sugammadex: a revolutionary approach to neuromuscular antagonism.

Kopman AF.

Anesthesiology. 2006 Apr;104(4):631-3. No abstract available.

PMID:
16571954
3.

THE THYMUS GLAND--ITS IMPLICATIONS IN CLINICAL ANESTHETIC PRACTICE.

WISE RP, WYLIE WD.

Clin Anesth. 1963;52:155-86. Review. No abstract available.

PMID:
14066270
4.

Sugammadex in anesthesia practice.

Duvaldestin P, Plaud B.

Expert Opin Pharmacother. 2010 Nov;11(16):2759-71. doi: 10.1517/14656566.2010.528391. Review. Erratum in: Expert Opin Pharmacother. 2010 Dec;11(17):2939-41.

PMID:
20977408
5.

[SOME DATA ON THE MECHANISM OF SO-CALLED RECURARIZATION].

KOVANEV VA, KHMELEVSKII IaM.

Eksp Khir Anesteziol. 1964 Jul-Aug;17:80-8. Russian. No abstract available.

PMID:
14246412
6.

Monitoring the neuromuscular junction.

Beemer GH, Cass NM.

Anaesth Intensive Care. 1988 Feb;16(1):62-6. Review. No abstract available.

PMID:
2966594
7.

Is it always necessary to antagonize residual neuromuscular block? Do children differ from adults?

Hunter JM.

Br J Anaesth. 1996 Dec;77(6):707-9. No abstract available.

8.

First human exposure to Org 25969.

Nigrovic V, Bhatt SB, Amann A.

Anesthesiology. 2006 Aug;105(2):427; author reply 427. No abstract available.

PMID:
16871080
9.

Sugammadex: a novel approach to reversal of neuromuscular blockade.

Aniskevich S, Leone BJ, Brull SJ.

Expert Rev Neurother. 2011 Feb;11(2):185-98. doi: 10.1586/ern.11.2. Review.

PMID:
21306205
10.

Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?

Lien CA.

Anesthesiology. 2010 Jan;112(1):16-8. doi: 10.1097/ALN.0b013e3181c5388f. No abstract available.

PMID:
19952723
11.

[ON THE USE OF AN ANTICURARE COMBINATION IN ANESTHESIA].

DEBONIS B.

Boll Soc Med Chir Cremona. 1963 Jan-Mar;17:57-62. Italian. No abstract available.

PMID:
14112952
12.

[The antidotes against curare in anesthesia. Personal experiences with the use of Nivaline].

D'AURIA C, NASTRI D.

Riforma Med. 1963 Jan 12;77:39-42. Italian. No abstract available.

PMID:
14024991
13.

THE PLACE OF NEOSTIGMINE IN THE PRACTICE OF ANESTHESIA.

MCINTYRE JW.

Anesth Analg. 1964 Nov-Dec;43:662-8. No abstract available.

PMID:
14230719
14.

THE CLINICAL APPLICATION OF NIVALIN AS AN ANTIDOTE OF CURARE.

STOYANOV E, VULCHANOVA S.

Nauchni Tr Vissh Med Inst Sofiia. 1963;42:45-8. No abstract available.

PMID:
14128111
15.

In vivo animal studies with sugammadex.

Booij LH, van Egmond J, Driessen JJ, de Boer HD.

Anaesthesia. 2009 Mar;64 Suppl 1:38-44. doi: 10.1111/j.1365-2044.2008.05869.x. Review.

16.

[Clinical evaluation of pyridostigmine bromide (Mestinon) as a curare-antagonist].

Shima T, Hashimoto Y, Shiozawa S, Iwatsuki K.

Masui. 1972 May;21(5):427-31. Japanese. No abstract available.

PMID:
4263013
17.

[Do we know all indications and side effects of sugammadex?].

Malinovsky JM, Plaud B, Debaene B, Mertes PM.

Ann Fr Anesth Reanim. 2011 Oct;30(10):709-10. doi: 10.1016/j.annfar.2011.08.003. Epub 2011 Sep 15. French. No abstract available. Erratum in: Ann Fr Anesth Reanim. 2011 Dec;30(12):945.

PMID:
21924861
18.

Urgent usage of sugammadex to treat residual neuromuscular blockade in the PACU.

Jones PM, Turkstra TP.

Anesth Analg. 2007 Sep;105(3):877; author reply 878. No abstract available.

PMID:
17717257
19.

Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.

Ren WH, Jahr JS.

Am J Ther. 2009 Jul-Aug;16(4):295-9. doi: 10.1097/MJT.0b013e31817fe2d7. Review.

PMID:
19535969
20.
Items per page

Supplemental Content

Write to the Help Desk